Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies

Abstract

Objective. Perphenazine (PPZ), as a typical antipsychotic medical substance, has the same effectiveness compared to atypical antipsychotic medications for the treatment of schizophrenia. Despite the lipophilic essence, PPZ encounters limited bioavailability caused by the first-pass metabolism following oral administration. In the present study, PPZ-containing solid lipid nanoparticles (PPZ-SLNs) were prepared and optimized based on different factors, including lipid and surfactant amount, to develop appropriate and safe novel oral dosage forms of PPZ. Methods. The solvent emulsification-evaporation method was utilized to form SLNs by using soybean lecithin, glycerol monostearate (GMS), and Tween 80. Statistical optimization was done by the Box-Behnken design method to achieve formulation with optimized particle size, entrapment efficiency, and zeta potential. Also, transmission electron microscopy, in vitro release behavior, differential scanning calorimetry (DSC), and powder X-ray diffractometry (P-XRD) studies and cytotoxicity studies were assessed. Results. Optimization exhibited the significant effect of various excipients on SLN characteristics. Our finding indicated that the mean particle size, zeta potential, and entrapment efficiency of optimized PPZ-SLN were, respectively, 104 ± 3.92 nm , − 28 ± 2.28 mV , and 83 % ± 1.29 . Drug release of PPZ-SLN was observed to be greater than 90% for 48 h that emphasized a sustained-release pattern. The DSC and P-XRD studies revealed the amorphous state of PPZ-SLN. FTIR spectra showed no incompatibility between the drug and the lipid. Performing cytotoxicity studies indicated no significant cytotoxicity on HT-29 cell culture. Conclusion. Our study suggests that PPZ-SLNs can make a promising vehicle for a suitable therapy of schizophrenia for the oral drug delivery system.

Gel-Dispersed Nanostructured Lipid Carriers Loading Thymol Designed for Dermal Pathologies

“…The compatibility of the mixture of total lipids (solid and liquid proportions) and the amount of TH to be encapsulated were assessed by differential scanning calorimetry (DSC) using a Mettler TA 4000 system (Greifensee, Switzerland). 32 , 33 This method is a thermodynamical tool for direct assessment of the heat energy uptake, which occurs in a sample within a regulated increase or decrease in temperature. The difference in the input energy required to match the temperature of the sample, would be the amount of excess heat absorbed (endothermic) or released (exothermic) by the molecule in the sample.…”

Formulation and in Vitro Characterization of the Solid Lipid Nanoparticles of Naftopidil for Enhancing Oral Bioavailability

“…The morphological analysis of optimized formulation was conducted using transmission electron microscopy at 100 kV. Few drops of the sample were placed on a 300-mesh carbon-coated copper grid and dried at room temperature [22].…”

Statistical optimization of tetrahydrocurcumin loaded solid lipid nanoparticles using Box Behnken design in the management of streptozotocin-induced diabetes mellitus

“…Curcumin is a polyphenolic compound used in the treatment of various diseases. It is obtained from turmeric which is mentioned in Ayurveda as a medicinal plant of curcuma species ( Farsani et al, 2021 , Kumar et al, 2023 ). Tetrahydrocurcumin (THC) possesses the same pharmacological properties as curcumin as it is a major metabolite of curcumin.…”